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ABSTRACT	  Protein	   accumulation	   on	   chromatin	   has	   traditionally	   been	   studied	   using	  immunofluorescence	  microscopy	  or	  biochemical	   cellular	   fractionation	   followed	  by	  western	  immunoblot	  analysis.	  As	  a	  way	  to	  improve	  the	  reproducibility	  of	  this	  kind	  of	  analysis,	  make	  it	  easier	  to	  quantify	  and	  allow	  a	  stream-­‐lined	  application	  in	   high-­‐throughput	   screens,	   we	   recently	   combined	   a	   classical	  immunofluorescence	  microscopy	   detection	   technique	  with	   flow	   cytometry1.	   In	  addition	  to	  the	  features	  described	  above,	  and	  by	  combining	  it	  with	  detection	  of	  both	   DNA	   content	   and	   DNA	   replication,	   this	   method	   allows	   unequivocal	   and	  direct	   assignment	   of	   cell-­‐cycle	   distribution	   of	   protein	   association	   to	   chromatin	  without	   the	   need	   for	   cell	   culture	   synchronization.	   Furthermore,	   it	   is	   relatively	  quick	   (no	  more	   than	   a	   working	   day	   from	   sample	   collection	   to	   quantification),	  requires	   less	   starting	  material	   compared	   to	   standard	  biochemical	   fractionation	  methods	  and	  overcomes	  the	  need	  for	   flat,	  adherent	  cell	   types	  that	  are	  required	  for	  immunofluorescence	  microscopy.	  	   	  
INTRODUCTION	  Many	  proteins	   change	   their	   sub-­‐cellular	   localization	  during	   different	   phases	   of	  the	  cell	  cycle	  or	  in	  response	  to	  environmental	  stimuli.	  Such	  changes	  involve,	  for	  example,	   protein	   shuttling	   between	   cytoplasm	   and	   nucleus	   or	   between	  endoplasmic	   reticulum	   and	   cytoplasm.	   Cytoplasmic	   transcription	   factors	   that	  translocate	   to	   the	   nucleus	   in	   order	   to	   alter	   gene	   expression	   are	   a	  well-­‐known	  example.	   Other	   proteins,	   however,	   can	   alter	   their	   associative	   status	   with	   a	  particular	   subcellular	   environment,	   without	   even	   changing	   subcellular	  compartment.	   A	   prime	   example	   is	   provided	   by	   soluble	   nucleoplasmic	   proteins	  that	  become	  bound	  to	  chromatin	  under	  specific	  circumstances,	  such	  as	  at	  certain	  cell-­‐cycle	   stages	   or	   after	   DNA	   damage2.	   For	   example,	   proliferating	   cell	   nuclear	  antigen	  (PCNA)	  protein	  has	  been	  used	  as	  a	  marker	  of	  DNA	  replication	  (and,	  to	  a	  lesser	   extent,	   of	   DNA	   repair)	   as	   it	   can	   only	   be	   detected	   on	   chromatin	   when	  various	  replication	  factor	  complexes	  (RFCs)	  load	  it	  onto	  DNA3,4.	  Another	  example	  is	   that	   of	   the	   heterotrimeric	   replication	   protein	  A	   (RPA)	   complex	   (RPA1/2/3),	  which	   only	   becomes	   chromatin-­‐bound	   when	   its	   binding	   substrate,	   single-­‐stranded	  DNA	  (ssDNA),	  is	  exposed.	  As	  this	  only	  occurs	  during	  DNA	  replication	  in	  S	   phase	   or	   during	   some	   types	   of	   DNA	   repair	   mechanisms,	   RPA	   detection	   on	  chromatin	   can	   also	   serve	   as	   a	  way	   of	   identifying	   cells	   replicating	   or	   repairing	  their	  DNA5.	  	  
Development	  and	  applications	  of	  the	  protocol	  Classically,	   changes	   in	   sub-­‐cellular	   localization	   or	   chromatin	   association	   of	  proteins	   have	   been	   studied	   by	   biochemical	   cellular	   fractionation	   followed	   by	  western	  blot	   analysis.	  There	  are	   several	   limitations	   to	   this	   approach,	   including	  the	  fact	  that	  it	  is	  labour	  intensive,	  requires	  a	  considerable	  amount	  of	  starting	  cell	  material,	   is	   difficult	   to	   quantify	   and	   cannot	   be	   applied	   to	   medium-­‐	   or	   high-­‐throughput	  workflows.	  With	  the	  improvement	  of	  cell	  imaging	  techniques	  and	  the	  increasing	   availability	   of	   high	   quality	   antibodies,	   cellular	   immunofluorescence	  (IF)	  detection	  coupled	  to	  microscopy	  imaging	  has	  now	  become	  a	  standard	  way	  of	  following	   changes	   in	   sub-­‐cellular	   protein	   localization.	   Compared	   to	  immunoblotting-­‐based	  methods,	   it	   requires	   fewer	   cells,	   as	  observations	   can	  be	  made	   at	   a	   single-­‐cell	   level,	   and	   it	   is	   easier	   to	   quantify.	   Nevertheless,	   IF-­‐
microscopy-­‐based	   studies	   require	   a	   substantial	   amount	   of	   post-­‐acquisition	  analysis	   (especially	   if	   large	   numbers	   of	   cells	   need	   to	   be	   quantified),	   with	  requirement	   of	   very	   specialized	   quantitative	   imaging	   platforms	   not	   usually	  available	   to	   all	   research	   groups6,	   and	   IF-­‐microscopy	   is	   only	   really	   suitable	   for	  studying	  adherent	  and	  preferentially	  flat-­‐shaped	  cells.	  Cells	  grown	  in	  suspension	  and	   others	   that	   form	   spherical	   colonies,	   such	   as	   stem	   cells,	   are	   thus	   more	  difficult	  to	  study	  by	  IF-­‐microscopy	  experiments.	  	  Classical	   IF-­‐microscopy	   detection	   of	   protein	   localization,	   however,	   is	   not	  straightforward	   when	   changes	   in	   chromatin	   association,	   rather	   than	   in	   sub-­‐cellular	   localisation,	   are	   the	   subject	   of	   study.	   PCNA	   and	   RPA,	   for	   example,	   are	  highly	  abundant	  nuclear	  proteins.	  When	  cells	  start	  replicating	  their	  DNA,	  only	  a	  small	   fraction	   of	   these	   proteins	   becomes	   chromatin	   bound,	   accumulating	   at	  specific	  sub-­‐nuclear	  regions	  visualised	  as	  protein	  foci	  by	  IF-­‐microscopy3.	  Proper	  visualization	  of	  these	  foci,	  however,	  usually	  requires	  an	  in	  situ	  protein	  extraction	  step	  prior	   to	  protein	   fixation,	   to	   remove	   excess	  non-­‐chromatin	  bound	  protein7	  (Fig.	  1a).	  In	  order	  to	  simplify	  the	  analysis	  of	  larger	  cell	  populations,	  to	  widen	  the	  range	  of	   cell	   types	   that	  can	  be	  analysed,	   to	  establish	  a	  highly	   reproducible	  and	  quantifiable	   technique,	   and	   to	   simplify	   its	   application	   in	   high-­‐throughput	  experiments,	  we	  adapted	  the	  extraction	  protocol	  to	  flow	  cytometry1	  (Fig.	  1b)	  in	  a	  similar	  manner	  to	  what	  has	  been	  described	  for	  PCNA	  detection8.	  We	  used	  this	  approach	  to	  quantify	  RPA	  retention	  on	  chromatin	  in	  S-­‐phase	  cells	  and	  after	  DNA	  double-­‐strand	   break	   (DSB)	   induction	   in	   cells	   upon	   their	   exposure	   to	   DNA-­‐damaging	   agents1.	   RPA	   foci	   formation	   after	   DSB	   production	   is	   an	   indirect	  readout	   of	  DNA	   repair	   by	  homologous	   recombination	   (HR)9,	   and	   the	   excessive	  accumulation	   of	   RPA	   on	   chromatin	   in	   replicating	   cells	   is	   a	   good	   marker	   of	  replication	  stress10,	  a	  key	  feature	  of	  many	  cancer	  cells11.	  IF-­‐microscopy	  detection	  of	  RPA	  foci	  in	  cells	  has	  thus	  been	  used	  to	  detect	  cells	  undergoing	  DSB	  repair	  by	  HR12	  or	   to	  detect	  conditions	  of	   replicative	  stress6.	  Our	   flow	  cytometry	  protocol	  has	   proven	   useful	   in	   all	   these	   scenarios13-­‐18,	   and	   similar	   approaches	   to	   detect	  RPA	  binding	  to	  chromatin	  have	  also	  been	  reported19,20.	  Furthermore,	  we	  recently	  implemented	   this	   approach	   to	   quantify	   how	   another	   key	   HR	   factor,	   CtIP,	  accumulates	   on	   chromatin	   upon	   DNA-­‐damage	   induction21.	   We	   therefore	   think	  
that	   our	   method	   has	   the	   potential	   to	   be	   applied	   to	   the	   detection	   of	   many	  different	  chromatin-­‐binding	  factors	  in	  multiple	  cell	  types	  and	  analytical	  formats.	  	  
Limitations	  of	  the	  method	  As	  with	   all	   IF	   techniques,	   this	  method	   relies	   on	   the	   availability	   of	   high	   quality	  antibodies	  that	  unequivocally	  recognise	  the	  studied	  protein.	  A	  quick	  way	  to	  test	  whether	   an	   antibody	   can	   be	   used	   for	   IF-­‐flow	   cytometry	   is	   to	   check	  whether	   it	  works	   on	   IF-­‐microscopy.	   This	   approach	   can	   also	   help	   to	   identify	   the	   best	  extraction	   conditions	   for	   detecting	   the	   protein	   of	   interest	   with	   the	   minimum	  possible	  background22.	  It	  is	  also	  important	  to	  test	  the	  specificity	  of	  the	  antibody,	  either	   in	   cells	   defective	   for	   the	   protein	   of	   interest	   or	   in	   cells	  where	   the	   target	  protein	  has	  been	  depleted	  (for	  example,	  using	  small-­‐interfering	  RNAs	  or	  short-­‐hairpin	   RNAs),	   or	   has	   been	   inactivated	   genetically	   by	   CRISPR-­‐Cas9	   or	   other	  genome-­‐editing	  methods23.	  Once	  such	  controls	  have	  been	  performed,	  it	  is	  useful	  to	   know	   that,	   as	   a	   rule-­‐of-­‐thumb,	  most	   antibodies	   that	  work	   on	   IF-­‐microscopy	  will	  work	  on	  IF-­‐flow	  cytometry,	  but	  one	  will	  usually	  need	  to	  use	  them	  at	  higher	  concentration	   for	   IF-­‐flow	   cytometry.	   See	  Tables	   1	   and	   2	   for	   some	   examples	   of	  antibody	  conditions	  for	  flow	  cytometry	  tested	  in	  our	  laboratory.	  In	  the	  absence	  of	  high-­‐quality	  highly	   specific	   antibodies,	   tagging	   the	  protein	  of	   interest	  with	  a	  fluorescent	   molecule	   can	   overcome	   the	   problem21,	   although	   the	   experimenter	  has	   to	   take	   into	   account	   that	   the	   fluorescent	   tag	   could	   change	   the	   chromatin-­‐binding	  abilities	  of	  the	  protein	  being	  studied.	  Testing	  chromatin	  association	  with	  differentially	   tagged	   recombinant	   constructs	   (in	   the	   N-­‐	   or	   C-­‐terminus	   of	   the	  protein	  of	   interest,	   for	  example)	  or	  with	  different	  fluorescent	  proteins	  can	  help	  to	   address	   this	   issue.	  A	   classical	   biochemical	   cellular	   fractionation	   followed	  by	  western	  blot	  analysis	  of	  the	  fractions	  comparing	  tagged	  and	  untagged	  versions	  of	  the	  protein	  (if	  antibodies	  compatible	  with	  western	  blotting	  are	  available)	  can	  be	  an	  alternative	  way	  to	  confirm	  the	  validity	  of	  the	  tagging	  approach.	  	  This	  method	  has	  been	  successfully	  used	  on	  a	  wide	  range	  of	  different	  mammalian	  cell	   lines,	   including	   transformed,	   immortalised	   and	   primary	   cell	   lines.	   So	   far,	  human	  osteosarcoma	  U2OS	  cells,	  human	  colon	  carcinoma	  HCT-­‐116	  cells,	  human	  leukaemia	   HAP-­‐1	   cells,	   human	   immortalised	   retinal	   RPE-­‐1	   cells	   and	   primary	  
mouse	  embryonic	  fibroblasts	  have	  all	  yielded	  positive	  results.	  However,	  certain	  cell	   types	   may	   not	   be	   well	   suited	   to	   this	   kind	   of	   methodology.	   In	   our	   hands,	  human	   embryonic	   kidney	   HEK-­‐293	   cells	   cannot	   be	   used	   with	   this	   method,	   as	  they	  seem	  to	  be	  extremely	  sensitive	  to	  all	  extraction	  conditions.	  It	  is	  important	  to	  note	  that	  this	  seems	  to	  be	  more	  of	  an	  exception	  than	  the	  norm,	  given	  that	  it	  is	  the	  only	  cell	  line	  we	  have	  tested	  so	  far	  where	  this	  method	  could	  not	  be	  used.	  	  Another	  potential	  limitation	  of	  the	  method	  is	  the	  fact	  that	  it	  is	  unlikely	  to	  be	  able	  to	  detect	   changes	   in	   the	  nature	  of	  protein	  chromatin	   localization.	  Proteins	   that	  change	   their	   distribution	   on	   chromatin,	   but	   not	   their	   chromatin	   association	  status	  per	  se,	  might	  not	  show	  measurable	  differences.	  Several	  proteins	  involved	  in	  the	  DNA-­‐damage	  response	  exhibit	  this	  kind	  of	  chromatin	  redistribution	  upon	  DNA	   damage.	   MDC1	   and	   53BP1,	   for	   example,	   are	   constitutively	   chromatin-­‐associated	   and	   show	   a	   pan-­‐nuclear	   distribution.	   After	   DNA-­‐damage	   induction,	  they	   then	   redistribute	   to	   concentrate	   in	   chromatin-­‐flanking	  DNA	   damage	   sites	  within	  so-­‐called	  DNA	  repair	  foci2.	  Such	  changes	  are	  unlikely	  to	  be	  detected	  on	  a	  regular	  flow	  cytometer,	  given	  that	  the	  overall	  fluorescent	  intensity	  in	  the	  nucleus	  will	  not	   change.	  A	  potential	  way	   to	  overcome	   this	  problem	  could	  be	   the	  use	  of	  imaging	  flow	  cytometry	  platforms,	  where	  each	  analysed	  cell	   is	  also	  imaged	  and	  processed	   in	   a	   post-­‐acquisition	   manner24,25.	   Alternatively,	   high-­‐content	  quantitative	  microscopy	  techniques,	  such	  as	  the	  recently	  described	  quantitative	  image-­‐based	  cytometry	  (QIBC)	  method6,	  could	  also	  be	  applied.	  	  
Experimental	  design	  Typically,	   1-­‐1.5	   x	   106	   cells	   per	   sample	   are	   required,	   as	   the	   protein	   extraction	  performed	  before	  fixation	  will	  considerably	  reduce	  the	  pelleted	  cell	  volume.	  For	  the	  majority	  of	   cell	   lines,	  a	   fairly	  confluent	   (70-­‐80%	  confluence)	  6	  cm	  dish	  per	  sample	   at	   the	   time	   of	   collection	  will	   suffice,	   although	   different	   cell	   lines	   could	  require	  some	  optimization.	  Accordingly,	  all	  volumes	  stated	  in	  this	  procedure	  are	  optimized	   for	   samples	   in	   6	   cm	   dishes.	   When	   designing	   the	   experiment,	   it	   is	  important	   to	   include	   a	   control	   sample	   (e.g.	   if	   antibody-­‐based	   detection	   is	  performed,	   no	   primary	   antibody	   is	   added).	   This	   will	   allow	   detection	   of	   the	  background	   signal	   derived	   from	   the	   fluorophores,	   and	   is	   an	   important	   step	   in	  
setting	   up	   quantification	   gates	   (see	   ‘Procedure:	   Sample	   Analysis’).	   When	  fluorescent-­‐protein	   tags	   are	   used	   instead	   of	   antibodies,	   the	   control	   sample	  should	  be	  cells	  expressing	  the	  tag	  not	  fused	  to	  the	  protein	  of	  interest.	  	  The	  most	  critical	  step	  in	  this	  procedure	  is	  the	  extraction	  step	  performed	  prior	  to	  fixation	  of	   samples	   (Fig.	   2).	   Choosing	   the	   right	   extraction	  buffer	   is	   key	   for	   the	  success	  of	  the	  experiment.	  We	  have	  tested	  three	  different	  buffers:	  PBS-­‐T,	  RNase	  buffer	  and	  CSK	  buffer	  (see	  ‘Materials:	  Reagent	  Setup’).	  Of	  these,	  PBS-­‐T	  represents	  the	  harshest	  extraction	  condition,	  while	  RNase	  and	  CSK	  buffers	  are	  milder,	  thus	  allowing	   detection	   of	   proteins	  with	  weaker	   associations	  with	   chromatin.	   Note,	  however,	   that	   the	   strength	   of	   the	   RNase	   and	   CSK	   buffers	   can	   be	   modified	   by	  increasing	  or	  decreasing	   salt	   and	  detergent	   concentrations.	  Heavily	   chromatin-­‐bound	  proteins	  such	  as	  histones	  or	  RPA	  can	  be	  detected	  using	  PBS-­‐T1.	  CSK	  buffer	  has	  been	  used	  to	  detect	  chromatin	  association	  of	  the	  HR	  factor	  CtIP,	  and	  it	  also	  allows	   RPA	   detection21	   (Table	   1).	   Buffers	   lacking	   or	   containing	   RNase	   can	   be	  useful	   when	   studying	   proteins	   that	   have	   varying	   requirements	   for	   RNA	  when	  binding	   chromatin22,26,	   therefore	   allowing	   one	   to	   study	   RNA-­‐independent	   and	  RNA-­‐dependent	  association	  modes.	  We	  recommend	  combining	  detection	  of	   the	  protein	   of	   interest	   with	   an	   already	   characterized	   antibody	   for	   a	   protein	   with	  known	  chromatin	  association	  status	   in	   the	  staining	  procedure,	  especially	  when	  testing	   an	   antibody	   against	   the	   protein	   of	   interest	   for	   the	   first	   time.	   This	  established	   antibody	  will	  work	   as	   an	   internal	   positive	   control.	   RPA	   antibodies	  are	  a	  good	  option	  for	  this,	  as	  they	  will	  always	  detect	  replicating	  cells	  (see	  Table	  
1	  for	  conditions).	  	  If	   cell-­‐cycle	   distribution	   of	   protein	   association	   to	   chromatin	   is	   potentially	  important	   for	   analysis,	   labeling	   of	   DNA-­‐replicating	   cells	   should	   be	   considered.	  Detection	   of	   replicating	   cells	   has	   been	   greatly	   simplified	   by	   the	   use	   of	   the	  nucleotide	   analogue	   5-­‐ethynyl-­‐2'-­‐deoxyuridine	   (EdU)	   and	   click	   chemistry27,28.	  Adding	  the	  cell-­‐permeable	  EdU	  to	  the	  medium	  allows	  its	  incorporation	  into	  DNA	  via	  replication.	  Consequently,	  this	  enables	  the	  unequivocal	  fluorescent	  detection	  of	  cells	  in	  S	  phase	  of	  the	  cell	  cycle	  and,	  combined	  with	  total	  DNA	  staining	  using	  fluorescent	   DNA	   intercalating	   agents	   such	   as	   4',6-­‐diamidino-­‐2-­‐phenylindole	  
(DAPI)	   or	   propidium	   iodide	   (PI),	   this	   will	   ensure	   unambiguous	   assignment	   of	  protein	  association	   to	  chromatin	   to	  different	  cell-­‐cycle	  stages	  without	   the	  need	  for	   cell	   culture	   synchronization	   (see	   ‘Procedure:	   Sample	   Analysis’	   and	  Box	   1).	  Moreover,	  co-­‐staining	  with	  a	  chromatin	  mark	  such	  as	  histone	  H3	  phosphorylated	  on	   serine	   10	   (Table	   1)	   will	   also	   allow	   assignment	   of	   protein	   association	   to	  chromatin	  to	  mitotic	  cells29,	  a	  particularly	  challenging	  analysis	  when	  performing	  IF-­‐microscopy.	  	  Samples	   can	   be	   analysed	   in	   any	   flow	   cytometer.	   However,	   it	   is	   important	   to	  check	   the	   laser	   equipment	   of	   the	   flow	   cytometer	   in	   order	   to	   choose	   which	  fluorophores	   can	   be	   used.	   Also,	   the	   experimenter	   should	   carefully	   plan	   in	  advance	  how	  many	  fluorophores	  will	  need	  detection,	  especially	  if	  EdU	  and	  total	  DNA	  staining	  will	  also	  be	  performed	  (Table	  3).	  	   	  
MATERIALS	  	  
Reagents	  
• Trypsin-­‐EDTA	   (Life	   Technologies	   cat.	   no.	   25200-­‐056),	   or	   an	   alternative	  cell	   dissociation	   reagent.	   No	   need	   to	   work	   under	   sterile	   conditions.	   If	  using	  trypsin,	  keep	  it	  at	  4	  °C	  until	  its	  use	  (stable	  for	  18	  months).	  
• 1x	  PBS	  pH	  7.2-­‐7.4	  (Life	  Technologies	  cat.	  no.	  10010-­‐023)	  
• Triton	  X-­‐100	  (Sigma,	  cat.	  no.	  T8787)	  CAUTION	  Hazardous	  in	  case	  of	  eye	  contact,	   ingestion	  or	   inhalation.	  Handle	   in	  a	   fume	  hood,	  using	  protective	  gloves	  and	  eyewear.	  
• PIPES	  (Sigma,	  cat.	  no.	  P1851),	  pH	  7.0	  
• Sodium	  chloride	  (NaCl)	  
• Magnesium	  chloride	  (MgCl2)	  
• Sucrose	  (Sigma,	  cat.	  no.	  S0389)	  
• RNase	  A	  (Sigma,	  cat.	  no.	  R5500)	  
• HEPES	  (Sigma,	  cat.	  no.	  H3375),	  pH	  7.4	  
• EDTA	  pH	  8.0	  
• Protease	   inhibitors	   (cOmplete	   protease	   inhibitor	   cocktail	   tablets,	   Roche	  cat.	  no.	  11697498001)	  
• BSA	  (Sigma,	  cat.	  no.	  A3059)	  
• Paraformaldehyde	  (Sigma,	  cat.	  no.	  P6148)	  
• BD	  Perm/Wash	  buffer	  (Becton-­‐Dickinson,	  cat.	  no.	  BD554723)	  
• 1x	  DPBS	  (Life	  Technologies	  cat.	  no.	  14190-­‐144)	  
• Heat-­‐inactivated	   foetal	   bovine	   serum	   (Life	   Technologies	   cat.	   no.	   10082-­‐147)	  
• Sodium	  azide	  (Sigma	  cat.	  no.	  438456)	  CAUTION	  Extremely	   toxic	   in	  case	  of	   contact,	   ingestion	   or	   inhalation.	   Handle	   in	   a	   fume	   hood,	   using	  protective	  gloves	  and	  eyewear.	  • Dimethyl	   sulfoxide	   (DMSO;	   Fisher,	   cat.	   no.	   A4034)	   CAUTION	   It	   readily	  permeates	   skin,	   is	   a	   combustible	   liquid	   and	   vapor,	   and	   is	   hygroscopic.	  Handle	  using	  protective	  gloves.	  • Tris-­‐HCl,	  pH	  7.4	  • Sodium	  acetate,	  pH	  5.2	  
• 4',6-­‐diamidino-­‐2-­‐phenylindole	  (DAPI;	  Sigma	  cat.	  no.	  D9542)	  • Optional:	  propidium	  iodide	  (PI;	  Sigma	  cat.	  no.	  P4170)	  	  
Equipment	  
• 0.45	  µm	  pore	  size	  minisart	  filters	  (Sigma	  cat.	  no.	  16555K	  SUPELCO)	  
• 37	  °C	  water	  bath	  
• 15	  ml	  conical	  tubes	  
• 37	  °C	  incubator	  
• Phase	  contrast	  microscope	  
• Tabletop	  refrigerated	  centrifuge	  (4˚C)	  for	  15	  ml	  conical	  tubes	  
• 5	   ml	   polystyrene	   (Corning	   cat.	   no.	   352058)	   or	   polypropylene	   (Corning	  cat.	  no.	  352063)	  round-­‐bottom	  tubes	  (check	  compatibility	  with	  your	  flow	  cytometer)	  
• Flow	  cytometer.	  We	  use	  an	  LSR	  Fortessa	  Cell	  Analyzer	  (BD	  Biosciences)	  
• Flow	  cytometry	  software	  analysis.	  We	  use	  FlowJo	  (TreeStar)	  	  
Reagent	  setup	  
RNase	  A:	  dissolve	  the	  RNase	  A	  in	  a	  10	  mM	  sodium	  acetate	  (pH	  5.2),	  10	  mM	  Tris-­‐HCl	   (pH	  7.4)	   solution.	  Heat	   strongly	   to	   dissolve.	   The	   solution	   can	  be	   aliquoted	  and	  kept	  indefinitely	  at	  -­‐20	  °C.	  
Extraction	  buffers	  (use	  one	  of	  the	  following)	  
PBS-­‐T:	   prepare	   a	   0.2%	   (v/v)	   Triton	   X-­‐100	   solution	   in	   1x	   PBS.	   This	   solution	  remains	  stable	  indefinitely	  at	  room	  temperature	  (20-­‐25	  °C)	  
RNase	   buffer:	   combine	  10	  mM	  PIPES	  pH	  7.0,	  100	  mM	  NaCl,	  3	  mM	  MgCl2,	  300	  mM	   sucrose,	   0.7%	   Triton	   X-­‐100.	   This	   solution	   remains	   stable	   indefinitely	   at	  room	   temperature.	   Just	   before	   use,	   add	   0.3	   mg/ml	   RNase	   A	   to	   the	   volume	   of	  buffer	  needed	  for	  the	  experiment.	  
CSK	   buffer:	   combine	   25	  mM	  HEPES	   pH	   7.4,	   50	  mM	  NaCl,	   1	  mM	  EDTA,	   3	  mM	  MgCl2,	  300	  mM	  sucrose,	  0.5%	  Triton	  X-­‐100,	  cOmplete	  protease	  inhibitor	  cocktail	  tablet	  (1	  per	  50	  ml	  of	  buffer).	  This	  solution	  remains	  stable	  at	  4	  °C	  for	  a	  couple	  of	  weeks.	  For	  indefinite	  long-­‐term	  storage	  keep	  at	  -­‐20	  °C.	  
Other	  buffers	  (all	  required)	  
PBS-­‐B:	  prepare	  a	  1	  mg/ml	  BSA	  solution	  in	  1x	  PBS.	  This	  solution	  remains	  stable	  indefinitely	  at	  4	  °C.	  
Washing	   buffer:	   dilute	   BD	   Perm/Wash	   buffer	   1:10	   in	  water.	   Filter	   the	  solution	   using	   a	   0.45	   µm	   pore	   size	   filter	   to	   remove	   precipitates.	   This	  solution	  remains	  stable	  indefinitely	  at	  4	  °C.	  
Storage	  buffer:	  prepare	  a	  3%	  (v/v)	  heat-­‐inactivated	  foetal	  bovine	  serum,	  0.09%	   (w/v)	   sodium	   azide	   solution	   in	   1x	   DPBS.	   This	   solution	   remains	  stable	  indefinitely	  at	  room	  temperature.	  
Freezing	  buffer:	  prepare	  a	  10%	  DMSO	  solution	  in	  heat-­‐inactivated	  foetal	  bovine	  serum.	  This	  solution	  remains	  stable	  indefinitely	  at	  -­‐20	  °C.	  
Fixation	   buffer:	   2%	   (w/v)	  paraformaldehyde	   in	  1x	  PBS.	  Heat	   gently	   to	  dissolve.	  This	   solution	   remains	   stable	  at	  4	   °C	   for	  a	   couple	  of	  weeks.	  For	  long-­‐term	  indefinite	  storage	  keep	  at	  -­‐20	  °C.	  
Analysis	  buffer:	  0.02%	  (w/v)	  sodium	  azide,	  250	  µg/ml	  RNase,	  0.5	  µg/ml	  DAPI	   in	   PBS-­‐B.	   This	   solution	   remains	   stable	   indefinitely	   at	   4	   °C.	   PI	   (10	  µg/ml)	   can	   be	   used	   instead	   of	   DAPI,	   but	   it	   is	   not	   recommended	   if	   the	  proteins	   of	   interest	   are	   tagged	   with	   green	   or	   red	   fluorophores,	   as	   PI	  emission	  will	  interfere	  with	  green	  and	  red	  emissions.	  	   	  
PROCEDURE	  
	  
Cell	  culture	  preparation:	  Timing	  1-­‐4	  days	  1. Calculate	  the	  number	  of	  cell	  culture	  dishes	  needed	  for	  the	  experiment	  and	  seed	  the	  appropriate	  number	  of	  cells	  in	  the	  corresponding	  medium.	  
CRITICAL	  STEP:	  remember	  to	  include	  control	  samples.	  2. If	   combining	   protein	   detection	   with	   EdU	   incorporation	   (to	   assess	   cell-­‐cycle	  distribution	  of	  protein	  chromatin-­‐association)1,	  add	  the	  appropriate	  concentration	   of	   EdU	   to	   the	   plates	   15-­‐30	  min	   before	   sample	   collection	  (Box	  1).	  	  
Sample	  collection:	  Timing	  1-­‐1.5	  h	  for	  10-­‐20	  samples	  3. Warm	  up	  trypsin-­‐EDTA	  (1	  ml	  per	  sample)	  in	  the	  37	  °C	  water	  bath.	  4. Cool	  down	  a	  tabletop	  centrifuge	  to	  4	  °C.	  5. Put	  1x	  15	  ml	  conical	  tube	  per	  sample	  on	  ice.	  6. Pour	   off	   medium	   from	   the	   plates.	   If	   mitotic	   cells	   are	   important	   for	   the	  analysis,	   collect	   the	   medium	   directly	   into	   the	   15	   ml	   conical	   tubes;	  otherwise	  discard.	  7. Wash	   plates	  with	   2	  ml	   of	   1x	   PBS.	   If	  mitotic	   cells	   are	   important	   for	   the	  analysis,	  collect	  the	  wash	  directly	  into	  the	  15	  ml	  conical	  tubes;	  otherwise	  discard.	  8. Add	  1	  ml	  trypsin-­‐EDTA	  per	  plate	  and	  put	  plates	  in	  a	  37	  °C	  incubator	  for	  5	  min.	  9. After	   checking	   that	   cells	   are	   properly	   detached	   from	   the	   plate	   (use	   a	  phase	   contrast	  microscope	   to	   visualize	   if	   needed),	   transfer	   the	   trypsin-­‐EDTA	  cell	  suspension	  into	  the	  corresponding	  15	  ml	  conical	  tube	  (kept	  on	  ice)	  using	  a	  1	  ml	  pipette	  tip.	  10. Wash	  plates	  with	  2	  ml	  of	  1x	  PBS.	  Collect	  washes	   into	   the	  corresponding	  15	  ml	  conical	  tubes.	  11. Centrifuge	  the	  cell	  suspension	  for	  3	  min	  at	  400	  x	  g	  at	  4	  °C.	  12. Remove	  supernatant.	  
?TROUBLESHOOTING	  
13. Resuspend	  cell	  pellets	   in	  100	  µl	  of	  extraction	  buffer	  and	   incubate	  on	   ice	  for	   5-­‐10	   min.	   Cell	   suspensions	   can	   be	   transferred	   now	   to	   1.5	   ml	  microcentrifuge	  tubes,	  especially	  if	  many	  samples	  have	  to	  be	  handled.	  
CRITICAL	   STEP:	   we	   recommend	   you	   start	  with	   the	  weakest	   extraction	  buffer	   if	   testing	  chromatin	  retention	  of	  a	  given	  protein	   for	   the	   first	   time	  (see	  Limitations	  section	  in	  Introduction).	  14. Add	  2	  ml	  of	  PBS-­‐B	  per	  tube,	  keeping	  the	  tubes	  on	  ice.	  
CRITICAL	  STEP:	  wash	  with	  PBS-­‐B	  rather	  than	  PBS,	  as	  BSA	  prevents	  cells	  from	  adhering	  to	  the	  tube	  walls	  and	  helps	  them	  to	  pellet	  properly.	  15. Centrifuge	  the	  cell	  suspension	  for	  3	  min	  at	  400	  x	  g	  at	  4	  °C.	  16. Remove	  supernatant	  very	  carefully	  (with	  a	  tip	  of	  using	  suction)	  to	  avoid	  losing	  cell	  pellet.	  
?TROUBLESHOOTING	  17. Fix	  cell	  pellets	  in	  100	  µl	  fixation	  buffer	  and	  incubate	  at	  room	  temperature	  for	  15-­‐30	  min.	  
CRITICAL	   STEP:	   paraformaldehyde	   fixation	   is	   essential	   if	   the	  protein	   is	  labelled	  with	  a	  fluorescent	  protein,	  such	  as	  GFP,	  because	  ethanol	  fixation	  results	  in	  loss	  of	  fluorescence.	  
?TROUBLESHOOTING	  18. Add	  0.5	  ml	  of	  washing	  buffer	  per	  tube	  and	  mix	  cells	  by	  pipetting	  up	  and	  down.	  19. Centrifuge	   the	   cell	   suspension	   for	   3	   min	   at	   400	   x	   g.	   From	   now	   on,	   all	  centrifugations	  can	  be	  performed	  at	  room	  temperature.	  20. Remove	  supernatant.	  
PAUSE	   POINT:	   cells	   can	   be	   stored	   now	   for	   up	   to	   2-­‐3	   days	   at	   4	   °C	   by	  resuspending	   them	   in	   100	   µl	   of	   storage	   buffer.	   They	   can	   also	   be	   stored	  long	  term	  indefinitely	  at	  -­‐80	  °C	  by	  resuspending	  them	  in	  100	  µl	  of	  freezing	  buffer.	  	  
Sample	  preparation:	  Timing	  1-­‐3	  h	  for	  10-­‐20	  samples	  21. If	  cells	  were	  stored	  at	  4	  °C,	  resuspend	  them	  in	  0.5	  ml	  of	  washing	  buffer.	  If	  cells	  were	   frozen,	   resuspend	   them	   in	  0.5	  ml	   storage	  buffer.	   If	   cells	  have	  not	  been	  stored	  and	  are	  used	  fresh,	  go	  directly	  to	  step	  25.	  
22. Centrifuge	  the	  cell	  suspension	  for	  3	  min	  at	  400	  x	  g.	  23. Remove	  supernatant.	  24. If	  cells	  were	  stored	  at	  4	  °C,	  go	  to	  step	  25.	  If	  they	  were	  frozen,	  resuspend	  them	  in	  0.5	  ml	  of	  washing	  buffer,	  and	  repeat	  steps	  22	  and	  23.	  25. If	   antibody	   staining	   is	   not	   required	   (i.e.	   the	   protein	   is	   tagged	   with	   a	  fluorescent	  marker),	  go	  directly	  to	  step	  36.	  26. Antibody	   staining.	   Prepare	   50	   µl	   of	   washing	   buffer	   containing	   the	  appropriate	  dilution	  of	  primary	  antibody	  per	   sample	  and	  resuspend	   the	  cell	   pellet	   in	   it	   (see	   Table	   1	   for	   guidelines	   on	   dilutions	   of	   primary	  antibodies).	  
CRITICAL	   STEP:	   remember	   to	   set	  up	  a	   control	   sample	  with	  no	  primary	  antibody	   (simply	   resuspend	   the	   cell	   pellet	   in	   washing	   buffer).	   We	   also	  recommend	   setting	   up	   a	   positive	   control	   plate	   using	   an	   established	  primary	  antibody	  raised	  in	  a	  different	  species	  (see	  Table	  1	  for	  examples).	  27. Incubate	  at	  room	  temperature	  for	  at	  least	  1	  h.	  If	  the	  primary	  antibody	  is	  already	   conjugated	   to	   a	   fluorescently-­‐labelled	   secondary	   antibody,	  perform	  the	  incubation	  in	  the	  dark	  and	  go	  straight	  to	  step	  33.	  
PAUSE	   POINT:	   The	   primary	   antibody	   can	   be	   left	   on	   overnight	   if	   the	  samples	  are	  kept	  at	  4	  °C.	  28. Add	  0.5	  ml	  of	  washing	  buffer	  per	  tube.	  29. Centrifuge	  the	  cell	  suspension	  for	  3	  min	  at	  400	  x	  g.	  30. Remove	  the	  supernatant.	  31. Prepare	   50	   µl	   of	   washing	   buffer	   containing	   the	   appropriate	   dilution	   of	  secondary	   antibody	   per	   sample	   and	   resuspend	   the	   cell	   pellet	   in	   it	   (see	  
Table	  2	  for	  guidelines	  on	  dilutions	  of	  secondary	  antibodies).	  32. Incubate	  at	  room	  temperature	  in	  the	  dark	  for	  30	  min.	  33. Add	  0.5	  ml	  of	  washing	  buffer	  per	  tube.	  34. If	  measuring	  EdU	  incorporation,	  perform	  the	  click	  reaction	  now	  (see	  Box	  
1).	  Otherwise,	  go	  to	  step	  35.	  35. Centrifuge	  the	  cell	  suspension	  for	  3	  min	  at	  400	  x	  g.	  36. Remove	  the	  supernatant.	  37. Resuspend	  cell	  pellets	  in	  0.3-­‐0.5	  ml	  of	  analysis	  buffer.	  38. Transfer	  cell	  suspensions	  to	  5	  ml	  polystyrene	  round-­‐bottom	  tubes.	  
39. Incubate	  at	  37	  °C	  for	  20-­‐30	  min.	  
PAUSE	  POINT:	  if	  not	  analysed	  immediately,	  cells	  can	  be	  left	  at	  4	  °C	  away	  from	  light	  exposure	  for	  several	  days.	  In	  this	  case,	  they	  can	  be	  left	  without	  the	   37	   °C	   incubation	   stage	   (step	   39),	   as	   the	   RNase	   will	   work	   anyway	  during	  a	  protracted	  4	  °C	  incubation	  (the	  minimum	  time	  we	  have	  tested	  at	  4°C	  is	  12-­‐16	  h).	  	  
Sample	  analysis:	  Timing	  1-­‐2	  h	  for	  10-­‐20	  samples	  40. For	  the	  negative	  control	  sample	  (with	  no	  primary	  antibody	  or	  fluorescent	  protein	   is	   present), acquire	   events	  with	   linear	   side-­‐scatter	   area	   (SSC-­‐A-­‐lin)	   versus	   linear	   forward-­‐scatter	   area	   (FSC-­‐A-­‐lin)	   axes.	   Tune	   the	  acquisition	   speed	   between	  100-­‐200	   events	   per	   second.	   The	   SSC-­‐versus-­‐FSC	   plot	   should	   reveal	   a	   major	   population	   of	   cells.	   Center	   using	   the	  voltage	  and	  gain	  settings	  and	  create	  the	  first	  gate	  (R1)	  (Fig.	  3a).	  
?TROUBLESHOOTING	  41. Isolate	   cell	   doublets	   by	   plotting	   linear	   405	   nm	   area	   (405-­‐A-­‐lin)	   versus	  linear	  405	  nm	  height	  (405-­‐H-­‐lin)	  and	  set	  gate	  R2	  around	  single	  cells	  (Fig.	  
3b).	  Change	   the	  405	  nm	   laser	  voltage	   to	   center	   the	  population	  between	  50K	  and	  150K.	  If	  DAPI	  has	  not	  been	  used	  to	  stain	  DNA	  content,	  isolate	  cell	  doublets	   by	   plotting	   FSC-­‐width(W)-­‐lin	   versus	   FSC-­‐A-­‐lin	   and	   set	   gate	  R2	  around	  single	  cells	  (Fig.	  3c).	  42. Plot	   the	   detected	   fluorescence	   in	   histogram	   mode:	   counts	   versus	  logarithmic	   488/561/647	   nm	   area	   (488/561/647-­‐A-­‐log),	   depending	   on	  the	   fluorophore.	   Change	   the	   corresponding	   voltage	   to	   center	   the	  background	  peak	  at	  around	  102	  (Fig.	  3d).	  43. Save	  the	  experiment	  settings	  on	  the	  flow	  cytometer.	  44. Acquire	   the	   first	   sample	   (for	   example,	   unchallenged	   or	   unstimulated	  cells).	  We	  recommend	  acquiring	  at	  least	  5,000-­‐10,000	  events	  in	  R2.	  45. In	   the	  histogram	  plot,	   establish	  an	  arbitrary	  gate	   to	  define	  positive	  cells	  (R3)	  (Fig.	  3e).	  46. Acquire	  the	  second	  sample	  (for	  example,	  challenged	  or	  stimulated	  cells).	  If	  additional	  chromatin	  binding	  of	  the	  protein	  occurs,	  there	  should	  be	  an	  increase	  in	  cells	  in	  the	  R3	  gate	  (Fig.	  3f).	  
?TROUBLESHOOTING	  47. Export	   data	   and	   perform	   post-­‐acquisition	   analysis	   using	   appropriate	  software	  (e.g.,	  FlowJo).	  
CRITICAL	   STEP:	   Gating	   positive	   and	   negative	   cells	   for	   the	   presence	   or	  absence	   of	   a	   fluorescent	   mark	   is	   the	   most	   straightforward	   way	   of	  quantifying	  data.	  However,	  in	  some	  cases,	  it	  might	  be	  useful	  to	  analyse	  the	  fluorescence	   intensity	   per	   cell,	   as	   well	   as	   the	   percentage	   of	   cells	  displaying	  fluorescence.	  To	  do	  this,	  calculate	  the	  geometrical	  mean	  of	  the	  intensity	   of	   the	   total	   cell	   population	   from	   gate	   R21.	   This	   is	   particularly	  useful	  when	  chromatin	  association	  of	  the	  protein	  is	  not	  an	  all-­‐or-­‐nothing	  event,	   as	   subtle	   changes	   in	   fluorescence	   could	   be	   overlooked	   when	  establishing	  arbitrary	  gates.	  
	   	  
TROUBLESHOOTING	  	  
Step	   Problem	   Possible	  reason	   Possible	  solution	  12	   Little	   (or	   invisible)	  cell	  pellet	   Not	   enough	   starting	  material	  (cells)	   Increase	   the	  number	   of	   plated	  cells	  16	   Little	   (or	   invisible)	  cell	   pellet	   (see	   Supp.	  
Fig.	   1	   for	   an	   example	  of	   the	   pellet	   size	   to	  expect)	  
	  Not	   enough	   starting	  material	  (cells)	   Increase	   the	  number	   of	   plated	  cells.	   Be	   sure	   to	  use	  PBS-­‐B	  and	  not	  PBS	   to	   wash	   cells	  after	  extraction	  17	   Viscous	  cell	  pellet	   Nuclei	  have	  burst	  due	  to	  the	  extraction	  conditions	   Change	   extraction	  buffer	   to	   a	  milder	  one	  40	   No	  cells	  detected	   Cells	   out	   of	   normal	   voltage	  range	   Change	   voltage	  conditions.	  Remember	   that	  after	   treatment	  with	   the	  extraction	   buffer,	  samples	   are	  reduced	   to	   nuclei,	  as	   most	   of	   the	  cytoplasm	   will	  have	   been	  removed,	   making	  them	   smaller	  events	  to	  detect	  40	   Although	   there	   is	   a	  main	  population,	  most	  of	   the	   events	   are	  
Many	  nuclei	  have	  burst.	  The	  extraction	   conditions	   might	  be	  too	  harsh.	  
Change	   extraction	  buffer	   or	   reduce	  incubation	  time	  
displayed	   around	   the	  intersection	  of	  x	  and	  y	  axes	  40	   Too	   many	   events	  measured	  per	  second	   Final	   cell	   concentration	   too	  high	   Reduce	  acquisition	   speed	  in	   the	   flow	  cytometer.	   If	   that	  does	  not	  solve	  the	  problem,	   dilute	  the	   sample	   with	  more	   analysis	  buffer	  46	   No	  protein	  association	  to	  chromatin	  detected,	  not	   even	   for	   the	  positive	  control	  
Unsuccessful	   extraction	  prior	  to	  fixation	   Repeat	   the	  experiment,	  changing	  extraction	   buffer	  and	   conditions	   if	  necessary	  
	   	  
TIMING	  
	  
Day	  1	  Reagent	  Setup	  and	  step	  1,	  prepare	  all	  reagents	  and	  seed	  the	  appropriate	  number	  of	  cell	  culture	  dishes:	  3-­‐4	  h	  for	  10-­‐20	  samples.	  Box	   1,	   prepare	   all	   reagents	   for	   EdU	   detection	   assay	   (if	   analysing	   cell	   cycle	  distribution):	  1	  h.	  
Day	  2	  Steps	  3-­‐20,	  collect	  samples:	  1-­‐1.5	  h	  for	  10-­‐20	  samples	  Steps	   21-­‐39,	   prepare	   samples	   (including	   primary	   and	   secondary	   antibody	  staining):	  1-­‐3	  h	  for	  10-­‐20	  samples	  Box	  1,	  measure	  EdU	   incorporation	   (if	   analysing	  cell	   cycle	  distribution):	  1.5-­‐3	  h	  for	  10-­‐20	  samples	  
Day	  3	  Steps	  40-­‐47,	  analyse	  samples	   in	  a	   flow	  cytometer	  and	  perform	  post-­‐acquisition	  analysis:	  1-­‐2	  h	  for	  10-­‐20	  samples	  
	   	  
ANTICIPATED	  RESULTS	  
	  If	  preliminary	   IF-­‐microscopy	  experiments	  (with	   the	  same	  extraction	  conditions	  and	  antibodies)	  are	  successful,	  you	  should	  be	  able	  to	  detect	  protein	  association	  to	  chromatin.	   Including	  a	  negative	  control	  sample	  (for	  example,	  samples	  where	  expression	  of	  the	  protein	  has	  been	  silenced	  or,	  for	  fluorescently-­‐tagged	  proteins,	  those	  only	  expressing	  the	  tag	  (Fig.	  3d))	  will	  help	  to	  determine	  the	  specificity	  of	  the	   antibodies	   used,	   and	   confirm	   whether	   it	   is	   possible	   to	   accurately	   detect	  chromatin	  association	  of	  the	  protein	  (Fig.	  3e-­‐f).	  It	   is	   important	  to	  note	  that	  the	  ability	   to	   detect	   chromatin	   accumulation	   of	   different	   proteins	   can	   vary	  considerably,	  depending	  not	  only	  on	  antibody	  quality	  but	  also	  on	  the	  abundance	  and/or	  accessibility	  of	  protein	  molecules	  being	  detected.	  This	   is	  exemplified	  by	  comparing	  the	  chromatin	  associative	  status	  of	  CtIP	  (Fig.	  3)	  and	  RPA	  (Fig.	  4)	  after	  DNA	  damage.	  It	   is	  believed	  that	  few	  CtIP	  molecules	  accumulate	  at	  DNA-­‐damage	  sites,	  while	  ssDNA,	  RPA’s	  binding	  substrate,	  can	  extend	  to	  several	  kb	  at	  resected	  DSBs9,	  thus	  leading	  to	  extensive	  RPA	  chromatin	  association.	  Including	  a	  positive	  control	  sample	  (such	  as	  those	  stained	  with	  RPA;	  Fig.	  4)	  will	  allow	  you	  to	  identify	  problematic	   steps	   in	   case	   of	   negative	   results	   (see	   TROUBLESHOOTING),	   and	  confirm	  whether	  the	  assay	  has	  been	  run	  successfully.	  Combining	   detection	   of	   fluorescently-­‐labelled	   proteins	   with	   nucleotide	  incorporation	   (see	  Box	   1)	  and	  DNA-­‐labelling	   fluorophores,	   such	  as	  DAPI	  or	  PI,	  will	  allow	  immediate	  assignment	  of	  protein	  association	  to	  chromatin	  to	  specific	  cell-­‐cycle	   stages	   (Fig.	   4).	   The	   example	   shown	   in	   Figure	   4b	   (combination	   of	  protein	  detection	  with	  DAPI	  and	  EdU	  incorporation)	  is	  particularly	  informative,	  as	  it	  demonstrates	  the	  unequivocal	  detection	  of	  protein	  chromatin	  association	  in	  G1,	  S	  and	  G2	  phases	  of	  the	  cell	  cycle.	  Finally,	   we	   recommend	   analysing	   data	   both	   by	   establishing	   arbitrary	   positive	  and	   negative	   gates	   and	   by	   measuring	   the	   geometrical	   mean	   intensity	   of	   the	  detected	   fluorescence	   to	   ensure	   that	   subtle	   changes	   in	   protein	   association	   to	  chromatin	  are	  not	  overlooked	  (see	  Procedure	  Step	  47).	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FIGURE	  LEGENDS	  	  
Figure	   1.	   In	   situ	   extraction	   facilitates	   protein	   detection	   on	   chromatin.	   (a)	  Detection	  of	  RPA	  or	  PCNA	  foci	   in	  DNA	  replicating	  cells	  by	  IF	  is	  simplified	  by	  an	  extraction	  step	  that	  removes	  most	  of	  the	  soluble,	  non	  chromatin-­‐bound	  proteins.	  (b)	   Extraction	   in	   samples	   used	   for	   flow	   cytometry	   is	   essential	   to	   distinguish	  between	   replicating	   and	   non-­‐replicating	   cells	   through	   RPA	   staining.	   RPA	  detection	  with	  no	  extraction	  (panel	  1)	  results	  in	  the	  homogenous	  staining	  of	  the	  whole	   cellular	   population.	   The	   use	   of	   a	   negative	   control,	  where	   extraction	   has	  been	  performed	  but	  no	  antibody	  has	  been	  used	  (panel	  2),	  allows	  establishment	  of	   negative/positive	   gates	   (dotted	   line).	   Combining	   extraction	   with	   antibody	  detection	  now	  allows	  identification	  of	  RPA-­‐positive,	  S	  phase	  cells	  (panel	  3).	  	  
Figure	  2.	  Experimental	  workflow	  with	  some	  estimated	  timings.	  In	  this	  example,	  samples	   are	   stimulated	   to	   promote	   protein	   association	   to	   chromatin.	   Cells	   are	  collected	  by	  trypsinization	  and	  extracted	  with	  the	  appropriate	  extraction	  buffer.	  After	   extraction,	   samples	   are	   fixed	   in	   paraformaldehyde	   and	   sequentially	  incubated	   in	   primary	   and	   secondary	   antibodies.	   Following	   transfer	   to	   flow-­‐cytometer	   compatible	   tubes,	   samples	   are	   analysed	   and	   processed	   using	   the	  appropriate	  software.	  	  
Figure	  3.	  Analysis	  of	  protein	  association	  to	  chromatin	  by	  flow	  cytometry.	  (a)	  The	  main	  cell	  population	  is	  resolved	  from	  debris	  by	  region	  gate	  R1,	  created	  on	  side-­‐scatter	  area	  linear	  scale	  (SSC-­‐A)	  versus	  forward-­‐scatter	  area	  linear	  scale	  (FSC-­‐A).	  (b)	  Single	  cells	  can	  be	  isolated	  by	  region	  gate	  R2	  on	  the	  405	  nm	  laser	  area	  linear	  scale	   (405-­‐nm-­‐A)	   versus	   405	   nm	   laser	   height	   linear	   scale	   (405-­‐nm-­‐H)	   if	   DAPI	  was	   used	   to	   stain	   total	   DNA	   content.	   (c)	   Single	   cells	   can	   be	   isolated	   by	   region	  gate	   R2	   on	   forward-­‐scatter	   width	   linear	   scale	   (FSC-­‐W)	   versus	   forward-­‐scatter	  area	  linear	  scale	  (FSC-­‐A).	  (d)	  Histogram	  plot	  to	  define	  background	  signal.	  In	  this	  example,	  488	  nm	  laser	  area	  logarithmic	  scale	  (488-­‐nm-­‐A)	  was	  measured	  in	  cells	  not	  expressing	  GFP	  protein.	  (e)	  GFP-­‐positive	  cells	  are	  defined	  by	  region	  gate	  R3	  on	  the	  same	  kind	  of	  plot	  as	  shown	  in	  (d),	  and	  depicted	  in	  green.	  In	  this	  case,	  cells	  are	  expressing	  a	  GFP-­‐tagged	  version	  of	   the	  DNA-­‐end	  resection	   factor	  CtIP21.	   (f)	  
Increased	  GFP-­‐positive	   cells	   (in	   green)	   compared	   to	   (e),	   indicative	  of	  GFP-­‐CtIP	  binding	   to	  chromatin	   in	  response	   to	  8	  h	  of	   treatment	  with	   the	  DNA	  replication	  inhibitor	  hydroxyurea	  (1	  mM).	  	  
Figure	  4.	  Combining	  detection	  of	  protein	  association	  to	  chromatin	  with	  cell	  cycle	  markers.	  (a)	  RPA2-­‐positive	  cells	  (measured	  in	  the	  488-­‐nm-­‐A	  laser)	  are	  depicted	  in	  red	  on	  top	  of	  the	  cell	  cycle	  profile	  obtained	  by	  histogram	  plotting	  of	  the	  405	  nm	   laser	   area	   linear	   scale	   (405-­‐nm-­‐A)	   measuring	   DAPI	   content.	   Most	   RPA2-­‐positive	  cells	  appear	  in	  the	  DNA	  content	  region	  in-­‐between	  2n	  and	  4n,	  suggesting	  cells	   are	   in	   the	   process	   of	   replicating	   their	   DNA.	   (b)	   RPA2-­‐positive	   cells	  (measured	   in	   the	   488-­‐nm-­‐A	   laser)	   are	   depicted	   in	   green	   on	   top	   of	   the	   DNA-­‐replication	  profile	  obtained	  by	  plotting	  the	  647	  nm	  laser	  area	   logarithmic	  scale	  (647-­‐nm-­‐A)	  measuring	  incorporation	  of	  the	  nucleotide	  analogue	  EdU	  versus	  the	  405	  nm	  laser	  area	  linear	  scale	  (405-­‐nm-­‐A)	  measuring	  DAPI	  content.	  Most	  RPA2-­‐positive	   cells	   appear	   in	   the	   EdU-­‐positive	   cell	   population	   indicative	   of	   DNA-­‐replicating	  cells.	  	   	  
Table	  1	  |	  Primary	  antibodies	  
Protein	  target	   Extraction	  
buffer*	   Provider	   Species	   Dilution	  Histone	  H2A.X	  phospho-­‐Ser-­‐139	  (γH2AX)	  1,21,30	   Any	   Cell	  Signaling	  (Cat.	   no.	  2577)	  
Rabbit	   1:200	  
Upstate	  (Cat.	   no.	  05-­‐636)	  
Mouse	   1:200	  
Histone	   H3	   phospho-­‐Ser-­‐10	   Any	   Abcam	  (Cat.	   no.	  ab14955)	  
Mouse	   1:100	  
RPA21,19,21	   PBS-­‐T	   and	  CSK	   Merck	  (Cat.	   no.	  NA19L)	  
Mouse	   1:100	  
Abcam	  (Cat.	   no.	  ab2175)	  
Mouse	   1:500	  
RPA1	   PBS-­‐T	   and	  CSK	   Cell	  Signaling	  (Cat.	   no.	  2267)	  
Rabbit	   1:25	  
Epitomics	  (Cat.	   no.	  2589-­‐1)	  
Rabbit	   1:100	  
*	  See	  ‘Reagent	  Setup’	  	   	  
Table	  2	  |	  Secondary	  antibodies	  
Fluorophore	   Provider	   Species	   Dilution	  Alexa	  Fluor	  488	   Molecular	   Probes	  (Cat.	  no.	  A11034)	   Goat	  anti-­‐rabbit	   1:1000	  Molecular	   Probes	  (Cat.	  no.	  A11029)	   Goat	  anti-­‐mouse	   1:1000	  Alexa	  Fluor	  594	   Molecular	   Probes	  (Cat.	  no.	  A11037)	   Goat	  anti-­‐rabbit	   1:1000	  Molecular	   Probes	  (Cat.	  no.	  A11032)	   Goat	  anti-­‐mouse	   1:1000	  Alexa	  Fluor	  647	   Molecular	   Probes	  (Cat.	  no.	  A21245)	   Goat	  anti-­‐rabbit	   1:1000	  Molecular	   Probes	  (Cat.	  no.	  A21236)	   Goat	  anti-­‐mouse	   1:1000	  	  	   	  
Table	  3	  |	  Flow	  cytometer	  laser	  and	  filter	  equipment	  	  
Fluorophore	   Excitation	  laser	  
(nm)	  
Emission	  filters	   Acquisition	  scale	  
DAPI	   405	   450/50	   Linear	  Alexa	  Fluor	  488/GFP	   488	   530/40	   Logarithmic	  Alexa	  Fluor	  594/RFP/mCherry	   561	   610/20	   Logarithmic	  Alexa	  Fluor	  647/IFP	   635	   670/30	   Logarithmic	  	  	   	  
BOX	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• EdU	  (Life	  Technologies,	  cat.	  no.	  A10044)	  
• Copper	   (II)	   sulfate	   pentahydrate	   (CuSO4·5H2O;	   Fisher,	   cat.	   no.	   C489)	  
CAUTION	   It	   is	   toxic	   if	   swallowed	   and	   causes	   skin	   and	   eye	   irritation.	  Handle	  using	  protective	  gloves.	  
• (+)	  Sodium	  L-­‐ascorbate	  (Sigma,	  cat.	  no.	  A4034)	  
• Alexa	   Fluor	   azide	   (488:	   Life	   Technologies,	   cat.	   no.	   A10266;	   594:	   Life	  Technologies	  A10270;	  647:	  Life	  Technologies	  A10277)	  	  
Reagent	  setup	  
• EdU:	  prepare	  a	  10	  mM	  stock	  in	  1x	  PBS.	  Keep	  at	  -­‐20	  °C	  (stable	  for	  a	  year).	  
• CuSO4:	  prepare	   a	  100	  mM	  CuSO4	   stock	   in	  water.	   Can	  be	   stored	  at	   room	  temperature	  for	  several	  months.	  
• Alexa	  Fluor	  azides:	  dissolve	  to	  200	  μM	  stock	   in	  DMSO.	  Keep	  at	  -­‐20	  °C	   in	  small	   aliquots	   and	   protect	   from	   light	   (stable	   for	   several	   months).	  Minimise	  freeze-­‐thaw	  cycles.	  
• Sodium	  L-­‐ascorbate:	  prepare	  a	  20	  mg/ml	  (100	  mM)	  stock	  in	  water;	  limit	  exposure	  to	  air	  and	  store	  on	  ice	  until	  needed.	  Stocks	  can	  be	  kept	  at	  -­‐20	  °C	  for	  several	  months.	  Minimise	  freeze-­‐thaw	  cycles.	  
• Click	  cocktail	  (per	  sample):	  43.75	  µl	  1x	  PBS,	  1	  μl	  100	  mM	  CuSO4,	  0.25	  μl	  200	   μM	   Alexa	   Fluor	   azide,	   5	   μl	   100	  mM	   sodium	   ascorbate.	   Mix	   in	   that	  order.	  Prepare	  immediately	  before	  use,	  as	  the	  cocktail	  is	  only	  stable	  for	  15	  min.	  	  
PROCEDURE	  Timing:	  45-­‐60	  min	  1. Count	  cell	  numbers	  in	  each	  sample	  and	  transfer	  the	  same	  number	  of	  cells	  per	  sample	  into	  new	  tubes	  (normalize	  to	  the	  lowest	  number).	  
CRITICAL:	   the	   EdU	   click	   reaction	   requires	   similar	   cell	   numbers	   to	  perform	   equally	   in	   all	   samples.	   Significant	   differences	   in	   cell	   numbers	  between	   samples	  will	   result	   in	   staining	   differences	   not	   due	   to	   different	  experimental	  conditions	  but	  to	  differences	  in	  starting	  cell	  material.	  2. Centrifuge	  the	  cell	  suspension	  for	  3	  min	  at	  400	  x	  g.	  3. Remove	  the	  supernatant.	  4. Resuspend	  the	  cell	  pellet	  in	  50	  μl	  of	  click	  cocktail.	  5. Incubate	  at	  room	  temperature	  in	  the	  dark	  for	  at	  least	  30	  min.	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